{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:42:48Z","timestamp":1790710968848,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11033-021-06149-8","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T20:02:47Z","timestamp":1611432167000},"page":"1925-1934","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["SARS-COV-2 infection and lung tumor microenvironment"],"prefix":"10.1007","volume":"48","author":[{"given":"Naila","family":"Malkani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-3122","authenticated-orcid":false,"given":"Muhammad Usman","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"key":"6149_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"6149_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1183\/13993003.00359-2016","volume":"48","author":"J Malhotra","year":"2016","unstructured":"Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P (2016) Risk factors for lung cancer worldwide. Eur Respir J 48:889\u2013902. https:\/\/doi.org\/10.1183\/13993003.00359-2016","journal-title":"Eur Respir J"},{"key":"6149_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB et al (2015) The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10:1243\u20131260. https:\/\/doi.org\/10.1097\/JTO.0000000000000630","journal-title":"J Thorac Oncol"},{"key":"6149_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3978\/j.issn.2072-1439.2011.01.01","volume":"3","author":"PM Ellis","year":"2011","unstructured":"Ellis PM, Vandermeer R (2011) Delays in the diagnosis of lung cancer. J Thorac Dis 3:183\u2013188. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2011.01.01","journal-title":"J Thorac Dis"},{"key":"6149_CR5","doi-asserted-by":"publisher","first-page":"1800190","DOI":"10.1183\/13993003.00190-2018","volume":"51","author":"R Rami-Porta","year":"2018","unstructured":"Rami-Porta R, Call S, Dooms C, Obiols C, S\u00e1nchez M, Travis WD, Vollmer I (2018) Lung cancer staging: a concise update. Eur Respir J 51:1800190. https:\/\/doi.org\/10.1183\/13993003.00190-2018","journal-title":"Eur Respir J"},{"key":"6149_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","volume":"35","author":"HH Popper","year":"2016","unstructured":"Popper HH (2016) Progression and metastasis of lung cancer. Cancer Metastasis Rev 35:75\u201391. https:\/\/doi.org\/10.1007\/s10555-016-9618-0","journal-title":"Cancer Metastasis Rev"},{"key":"6149_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y (2020) Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 5:28. https:\/\/doi.org\/10.1038\/s41392-020-0134-x","journal-title":"Signal Transduct Target Ther"},{"key":"6149_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T, Zare P (2020) Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal 18:59. https:\/\/doi.org\/10.1186\/s12964-020-0530-4","journal-title":"Cell Commun Signal"},{"key":"6149_CR9","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27:5904\u20135912. https:\/\/doi.org\/10.1038\/onc.2008.271","journal-title":"Oncogene"},{"key":"6149_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","volume":"19","author":"NK Altorki","year":"2019","unstructured":"Altorki NK, Markowitz GJ, Gao D, Port JL, Saxena A, Stiles B, McGraw T, Mittal V (2019) The lung microenvironment: an important regulator of tumor growth and metastasis. Nat Rev Cancer 19:9\u201331. https:\/\/doi.org\/10.1038\/s41568-018-0081-9","journal-title":"Nat Rev Cancer"},{"key":"6149_CR11","doi-asserted-by":"publisher","first-page":"e94040","DOI":"10.1172\/jci.insight.94040","volume":"3","author":"M Fricker","year":"2018","unstructured":"Fricker M, Goggins BJ, Mateer S, Jones B, Kim RY, Gellatly SL, Jarnicki AG, Powell N, Oliver BG, Radford-Smith G, Talley NJ, Walker MM, Keely S, Hansbro PM (2018) Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction. JCI Insight 3:e94040. https:\/\/doi.org\/10.1172\/jci.insight.94040","journal-title":"JCI Insight"},{"key":"6149_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-319-24932-2_5","volume":"890","author":"V Mittal","year":"2016","unstructured":"Mittal V, El Rayes T, Narula N, McGraw TE, Altorki NK, Barcellos-Hoff MH (2016) The microenvironment of lung cancer and therapeutic implications. Adv Exp Med Biol 890:75\u2013110. https:\/\/doi.org\/10.1007\/978-3-319-24932-2_5","journal-title":"Adv Exp Med Biol"},{"key":"6149_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ctrv.2013.10.001","volume":"40","author":"SL Wood","year":"2014","unstructured":"Wood SL, Pernemalm M, Crosbie PA, Whetton AD (2014) The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer Treat Rev 40:558\u2013566. https:\/\/doi.org\/10.1016\/j.ctrv.2013.10.001","journal-title":"Cancer Treat Rev"},{"key":"6149_CR14","doi-asserted-by":"publisher","first-page":"e86459","DOI":"10.1371\/journal.pone.0086459","volume":"9","author":"A Murakami","year":"2014","unstructured":"Murakami A, Takahashi F, Nurwidya F, Kobayashi I, Minakata K, Hashimoto M, Nara T, Kato M, Tajima K, Shimada N, Iwakami S, Moriyama M, Moriyama H, Koizumi F, Takahashi K (2014) Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor. PLoS ONE 9:e86459. https:\/\/doi.org\/10.1371\/journal.pone.0086459","journal-title":"PLoS ONE"},{"key":"6149_CR15","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.2147\/OTT.S168317","volume":"11","author":"Y Chen","year":"2018","unstructured":"Chen Y, Tan W, Wang C (2018) Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial-mesenchymal transition. Onco Targets Ther 11:3817\u20133826. https:\/\/doi.org\/10.2147\/OTT.S168317","journal-title":"Onco Targets Ther"},{"key":"6149_CR16","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.2741\/3782","volume":"16","author":"W Chen","year":"2011","unstructured":"Chen W, Li Z, Bai L, Lin Y (2011) NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. Front Biosci 16:1172\u20131185. https:\/\/doi.org\/10.2741\/3782","journal-title":"Front Biosci"},{"key":"6149_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.taap.2014.10.022","volume":"282","author":"Y Liu","year":"2015","unstructured":"Liu Y, Luo F, Xu Y, Wang B, Zhao Y, Xu W, Shi L, Lu X, Liu Q (2015) Epithelial-mesenchymal transition and cancer stem cells, mediated by a long non-coding RNA, HOTAIR, are involved in cell malignant transformation induced by cigarette smoke extract. Toxicol Appl Pharmacol 282:9\u201319. https:\/\/doi.org\/10.1016\/j.taap.2014.10.022","journal-title":"Toxicol Appl Pharmacol"},{"key":"6149_CR18","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.3390\/ijms19082460","volume":"19","author":"A Saito","year":"2018","unstructured":"Saito A, Horie M, Nagase T (2018) TGF-\u03b2 signaling in lung health and disease. Int J Mol Sci 19:2460. https:\/\/doi.org\/10.3390\/ijms19082460","journal-title":"Int J Mol Sci"},{"key":"6149_CR19","first-page":"5163","volume":"8","author":"JX Liang","year":"2015","unstructured":"Liang JX, Gao W, Liang Y, Zhou XM (2015) Chemokine receptor CXCR4 expression and lung cancer prognosis: a meta-analysis. Int J Clin Exp Med 8:5163\u20135174","journal-title":"Int J Clin Exp Med"},{"key":"6149_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/jcm7100303","volume":"7","author":"O Wald","year":"2018","unstructured":"Wald O (2018) CXCR4 based therapeutics for non-small cell lung cancer (NSCLC). J Clin Med 7:303. https:\/\/doi.org\/10.3390\/jcm7100303","journal-title":"J Clin Med"},{"key":"6149_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"AE Gorbalenya","year":"2020","unstructured":"Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, Haagmans BL, Lauber C, Leontovich AM, Neuman BW, Penzar D (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536\u2013544. https:\/\/doi.org\/10.1038\/s41564-020-0695-z","journal-title":"Nat Microbiol"},{"key":"6149_CR22","doi-asserted-by":"publisher","DOI":"10.1071\/MA20013","author":"JS Mackenzie","year":"2020","unstructured":"Mackenzie JS, Smith DW (2020) COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don\u2019t. Microbiol Aust. https:\/\/doi.org\/10.1071\/MA20013","journal-title":"Microbiol Aust"},{"key":"6149_CR23","first-page":"3","volume":"42","author":"YA Malik","year":"2010","unstructured":"Malik YA (2010) Properties of Coronavirus and SARS-CoV-2. Malays J Pathol 42:3\u201311","journal-title":"Malays J Pathol"},{"key":"6149_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","volume":"172","author":"SA Lauer","year":"2020","unstructured":"Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J (2020) The Incubation Period of Coronavirus Disease 2019 (COVID-19) From publicly reported confirmed cases: estimation and application. Ann Intern Med 172:577\u2013582. https:\/\/doi.org\/10.7326\/M20-0504","journal-title":"Ann Intern Med"},{"key":"6149_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00647-20","author":"NK Dutta","year":"2020","unstructured":"Dutta NK, Mazumdar K, Gordy JT (2020) The nucleocapsid protein of SARS\u2013CoV-2: a target for vaccine development. J Virol. https:\/\/doi.org\/10.1128\/JVI.00647-20","journal-title":"J Virol"},{"key":"6149_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2286-9","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O\u2019Meara MJ, Rezelj VV, Guo JZ, Swaney DL et al (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. https:\/\/doi.org\/10.1038\/s41586-020-2286-9","journal-title":"Nature"},{"key":"6149_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271\u2013280. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"6149_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"key":"6149_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/978-3-030-22696-1","volume-title":"Angiotensin-(1\u20137): a comprehensive review","author":"RAS Santos","year":"2019","unstructured":"Santos RAS (2019) Angiotensin-(1\u20137): a comprehensive review. Springer Publications, Cham, p 132"},{"key":"6149_CR30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1101\/gad.338228.120","volume":"34","author":"G Ferone","year":"2020","unstructured":"Ferone G, Lee MC, Sage J, Berns A (2020) Cells of origin of lung cancers: lessons from mouse studies. Genes Dev 34:1017\u20131032. https:\/\/doi.org\/10.1101\/gad.338228.120","journal-title":"Genes Dev"},{"key":"6149_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury. Nat Med 11:875\u2013879. https:\/\/doi.org\/10.1038\/nm1267","journal-title":"Nat Med"},{"key":"6149_CR32","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Sakata M (2020) Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. PNAS 117:7001\u20137003. https:\/\/doi.org\/10.1073\/pnas.2002589117","journal-title":"PNAS"},{"key":"6149_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-020-01521-x","volume":"21","author":"M Matusiak","year":"2020","unstructured":"Matusiak M, Sch\u00fcrch CM (2020) Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics. Respir Res 21:1\u20136. https:\/\/doi.org\/10.1186\/s12931-020-01521-x","journal-title":"Respir Res"},{"key":"6149_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.08.926006","author":"T Meng","year":"2020","unstructured":"Meng T, Cao H, Zhang H, Kang Z, Xu D, Gong H, Wang J, Li Z, Cui X, Xu H, Wei H (2020) The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS. BioRxiv. https:\/\/doi.org\/10.1101\/2020.02.08.926006","journal-title":"BioRxiv"},{"key":"6149_CR35","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1111\/febs.15499","volume":"287","author":"P Xia","year":"2020","unstructured":"Xia P, Dubrovska A (2020) Tumor markers as an entry for SARS-CoV-2 infection? FEBS J 287:3677\u20133680. https:\/\/doi.org\/10.1111\/febs.15499","journal-title":"FEBS J"},{"key":"6149_CR36","doi-asserted-by":"publisher","first-page":"104759","DOI":"10.1016\/j.antiviral.2020.104759","volume":"177","author":"CJ Sigrist","year":"2020","unstructured":"Sigrist CJ, Bridge A, Le Mercier P (2020) A potential role for integrins in host cell entry by SARS-CoV-2. Antiviral Res 177:104759. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104759","journal-title":"Antiviral Res"},{"key":"6149_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","volume":"16","author":"D Schoeman","year":"2019","unstructured":"Schoeman D, Fielding BC (2019) Coronavirus envelope protein: current knowledge. Virol J 16:69. https:\/\/doi.org\/10.1186\/s12985-019-1182-0","journal-title":"Virol J"},{"key":"6149_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","volume":"181","author":"YZ Zhang","year":"2020","unstructured":"Zhang YZ, Holmes EC (2020) A genomic perspective on the origin and emergence of SARS-CoV-2. Cell 181:223\u2013227. https:\/\/doi.org\/10.1016\/j.cell.2020.03.035","journal-title":"Cell"},{"key":"6149_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3816\/CLC.2003.n.021","volume":"5","author":"S Ballaz","year":"2003","unstructured":"Ballaz S, Mulshine JL (2003) The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 5:46\u201362. https:\/\/doi.org\/10.3816\/CLC.2003.n.021","journal-title":"Clin Lung Cancer"},{"key":"6149_CR40","doi-asserted-by":"publisher","first-page":"102972","DOI":"10.1016\/j.critrevonc.2020.102972","volume":"150","author":"E Moujaess","year":"2020","unstructured":"Moujaess E, Kourie HR, Ghosn M (2020) Cancer patients and research during COVID-19 pandemic: a systematic review of current evidence. Crit Rev Oncol Hematol 150:102972. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102972","journal-title":"Crit Rev Oncol Hematol"},{"key":"6149_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21:335\u2013337. https:\/\/doi.org\/10.1016\/S1470-2045(20)30096-6","journal-title":"Lancet Oncol"},{"key":"6149_CR42","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S1470-2045(20)30310-7","volume":"21","author":"K Yang","year":"2020","unstructured":"Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, Lu H, Liu J, Yang J, Dong Y et al (2020) Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol 21:904\u2013913. https:\/\/doi.org\/10.1016\/S1470-2045(20)30310-7","journal-title":"Lancet Oncol"},{"key":"6149_CR43","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q et al (2020) Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 10:783\u2013791. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0422","journal-title":"Cancer Discov"},{"key":"6149_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/gb-2003-4-8-225","volume":"4","author":"JF Riordan","year":"2003","unstructured":"Riordan JF (2003) Angiotensin-I-converting enzyme and its relatives. Genome Biol 4:225. https:\/\/doi.org\/10.1186\/gb-2003-4-8-225","journal-title":"Genome Biol"},{"key":"6149_CR45","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","volume":"15","author":"S Tian","year":"2020","unstructured":"Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY (2020) Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 15:700\u2013704. https:\/\/doi.org\/10.1016\/j.jtho.2020.02.010","journal-title":"J Thorac Oncol"},{"key":"6149_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.25259\/SNI_351_2019","volume":"10","author":"RL Blaylock","year":"2019","unstructured":"Blaylock RL (2019) Viruses and tumor cell microenvironment: a brief summary. Surg Neurol Int 10:160. https:\/\/doi.org\/10.25259\/SNI_351_2019","journal-title":"Surg Neurol Int"},{"key":"6149_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/cgt.2015.11","volume":"22","author":"CR de Vries","year":"2015","unstructured":"de Vries CR, Kaufman HL, Lattime EC (2015) Oncolytic viruses: focusing on the tumor microenvironment. Cancer Gene Ther 22:169\u2013171. https:\/\/doi.org\/10.1038\/cgt.2015.11","journal-title":"Cancer Gene Ther"},{"key":"6149_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2332-7","author":"D Bojkova","year":"2020","unstructured":"Bojkova D, Klann K, Koch B, Widera M, Krause D, Ciesek S, Cinatl J, M\u00fcnch C (2020) Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. https:\/\/doi.org\/10.1038\/s41586-020-2332-7","journal-title":"Nature"},{"key":"6149_CR49","doi-asserted-by":"publisher","first-page":"e1007053","DOI":"10.1371\/journal.pcbi.1007053","volume":"15","author":"M Roy","year":"2019","unstructured":"Roy M, Finley SD (2019) Metabolic reprogramming dynamics in tumor spheroids: Insights from a multicellular, multiscale model. PLoS Comput Biol 15:e1007053. https:\/\/doi.org\/10.1371\/journal.pcbi.1007053","journal-title":"PLoS Comput Biol"},{"key":"6149_CR50","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","volume":"9","author":"KG de la Cruz-L\u00f3pez","year":"2019","unstructured":"de la Cruz-L\u00f3pez KG, Castro-Mu\u00f1oz LJ, Reyes-Hern\u00e1ndez DO, Garc\u00eda-Carranc\u00e1 A, Manzo-Merino J (2019) Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front Oncol 9:1143. https:\/\/doi.org\/10.3389\/fonc.2019.01143","journal-title":"Front Oncol"},{"key":"6149_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"},{"key":"6149_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","volume":"6","author":"A Shimabukuro-Vornhagen","year":"2018","unstructured":"Shimabukuro-Vornhagen A, G\u00f6del P, Subklewe M, Stemmler MJ, Schl\u00f6\u00dfer HA, Schlaak M, Kochanek M, B\u00f6ll B, von Bergwelt-Baildon MS (2018) Cytokine release syndrome. J Immunother Cancer 6:56. https:\/\/doi.org\/10.1186\/s40425-018-0343-9","journal-title":"J Immunother Cancer"},{"key":"6149_CR53","doi-asserted-by":"publisher","DOI":"10.31219\/osf.io\/mxsvw","author":"YL Woo","year":"2020","unstructured":"Woo YL, Kamarulzaman A, Augustin Y, Staines H, Altice F, Krishna S (2020) A genetic predisposition for cytokine storm in life-threatening COVID-19 infection. OSF Preprints. https:\/\/doi.org\/10.31219\/osf.io\/mxsvw","journal-title":"OSF Preprints"},{"key":"6149_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG (2012) Into the eye of the cytokine storm. Microbiol Mol Biol Rev 76:16\u201332. https:\/\/doi.org\/10.1128\/MMBR.05015-11","journal-title":"Microbiol Mol Biol Rev"},{"key":"6149_CR55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1128\/CVI.00636-12","volume":"20","author":"RV D'Elia","year":"2013","unstructured":"D\u2019Elia RV, Harrison K, Oyston PC, Lukaszewski RA, Clark GC (2013) Targeting the \u201ccytokine storm\u201d for therapeutic benefit. Clin Vaccine Immunol 20:319\u2013327. https:\/\/doi.org\/10.1128\/CVI.00636-12","journal-title":"Clin Vaccine Immunol"},{"key":"6149_CR56","doi-asserted-by":"publisher","first-page":"E384","DOI":"10.21037\/jtd.2017.03.118","volume":"9","author":"AB Schulze","year":"2017","unstructured":"Schulze AB, Schmidt LH (2017) PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients. J Thorac Dis 9:E384\u2013E386. https:\/\/doi.org\/10.21037\/jtd.2017.03.118","journal-title":"J Thorac Dis"},{"key":"6149_CR57","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.21037\/tlcr.2018.01.05","volume":"7","author":"MJ Mooradian","year":"2018","unstructured":"Mooradian MJ, Gainor JF (2018) Putting the brakes on CTLA-4 inhibition in lung cancer? Transl Lung Cancer Res 7:S35\u2013S38. https:\/\/doi.org\/10.21037\/tlcr.2018.01.05","journal-title":"Transl Lung Cancer Res"},{"key":"6149_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-74588-6_48","author":"AY Young","year":"2019","unstructured":"Young AY, Shannon VR (2019) Acute respiratory distress syndrome in cancer patients. Oncol Crit Care. https:\/\/doi.org\/10.1007\/978-3-319-74588-6_48","journal-title":"Oncol Crit Care"},{"key":"6149_CR59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41571-020-0328-8","volume":"17","author":"JJ Luke","year":"2020","unstructured":"Luke JJ, Ascierto PA (2020) Biology confirmed but biomarkers elusive in melanoma immunotherapy. Nat Rev Clin Oncol 17:198\u2013199. https:\/\/doi.org\/10.1038\/s41571-020-0328-8","journal-title":"Nat Rev Clin Oncol"},{"key":"6149_CR60","first-page":"252","volume":"73","author":"A Cai","year":"2020","unstructured":"Cai A, McClafferty B, Benson J, Ramgobin D, Kalayanamitra R, Shahid Z, Groff A, Aggarwal CS, Patel R, Polimera H, Vunnam R (2020) COVID-19: catastrophic cause of acute lung injury. S D Med 73:252\u2013260","journal-title":"S D Med"},{"key":"6149_CR61","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02049-2020","author":"MA Acosta","year":"2020","unstructured":"Acosta MA, Singer BD (2020) Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.02049-2020","journal-title":"Eur Respir J"},{"key":"6149_CR62","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5694\/mja2.50674","volume":"213","author":"PG Gibson","year":"2020","unstructured":"Gibson PG, Qin L, Puah SH (2020) COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust 213:54\u201356. https:\/\/doi.org\/10.5694\/mja2.50674","journal-title":"Med J Aust"},{"key":"6149_CR63","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S2213-2600(20)30370-2","volume":"8","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, Laffey J, Carrafiello G, Carsana L, Rizzuto C, Zanella A (2020) Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med 8:1201\u20131208. https:\/\/doi.org\/10.1016\/S2213-2600(20)30370-2","journal-title":"Lancet Respir Med"},{"key":"6149_CR64","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/1078155217745144","volume":"25","author":"CR Stroud","year":"2019","unstructured":"Stroud CR, Hegde A, Cherry C, Naqash AR, Sharma N, Addepalli S, Cherukuri S, Parent T, Hardin J, Walker P (2019) Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade. J Oncol Pharm Pract 25:551\u2013557. https:\/\/doi.org\/10.1177\/1078155217745144","journal-title":"J Oncol Pharm Pract"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06149-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-021-06149-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06149-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T16:12:27Z","timestamp":1614701547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-021-06149-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["6149"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06149-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,23]]},"assertion":[{"value":"11 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and\/or animals participants"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}